Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-22

Clinical Trial Update: Quality of Life With TESTIM®

View source ↗

Summary

The trial update reports results on quality of life in men with hypogonadism treated with TESTIM, a testosterone gel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTIM (TESTOSTERONE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Hypogonadism | Status: COMPLETED